BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 7188802)

  • 1. Antibodies to acetylcholine receptor in patients with thymoma but without myasthenia gravis.
    Cuénoud S; Feltkamp TE; Fulpius BW; Oosterhuis HJ
    Neurology; 1980 Feb; 30(2):201-2. PubMed ID: 7188802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma.
    Mygland A; Tysnes OB; Matre R; Volpe P; Aarli JA; Gilhus NE
    Ann Neurol; 1992 Oct; 32(4):589-91. PubMed ID: 1333745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-acetylcholine receptor antibodies.
    Vincent A; Newsom Davis J
    J Neurol Neurosurg Psychiatry; 1980 Jul; 43(7):590-600. PubMed ID: 7400823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
    Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
    Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-skeletal muscle and anti-acetylcholine receptor antibodies in patients with thymoma without myasthenia gravis: relation to the onset of myasthenia gravis.
    Ohta M; Itoh M; Hara H; Itoh N; Nishitani H; Hayashi K; Ohta K
    Clin Chim Acta; 1991 Sep; 201(3):201-5. PubMed ID: 1756593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of antiacetylcholine receptor antibody in patients with thymoma without myasthenia gravis complications.
    Sakuraba M; Onuki T; Nitta S
    Jpn J Thorac Cardiovasc Surg; 2001 Dec; 49(12):690-2. PubMed ID: 11808089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody.
    Nakajima J; Murakawa T; Fukami T; Sano A; Takamoto S; Ohtsu H
    Ann Thorac Surg; 2008 Sep; 86(3):941-5. PubMed ID: 18721587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Encephalopathy, peripheral neuropathy, dysautonomia, myasthenia gravis, malignant thymoma, and antiacetylcholine receptor antibodies in the CSF.
    Bogousslavsky J; Regli F; Doret AM; Fulpius BW; Ostinelli B; Rabinowicz T; Ruzicka J
    Eur Neurol; 1983; 22(5):301-6. PubMed ID: 6628458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial: Cause of weakness in myasthenia gravis.
    Grob D
    N Engl J Med; 1976 Mar; 294(13):722-3. PubMed ID: 1082544
    [No Abstract]   [Full Text] [Related]  

  • 10. Thymoma-associated myasthenia gravis without acetylcholine receptor antibodies.
    Rigamonti A; Lauria G; Piamarta F; Fiumani A; Agostoni E
    J Neurol Sci; 2011 Mar; 302(1-2):112-3. PubMed ID: 21236448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymoma-specific antibodies in sera from patients with myasthenia gravis demonstrated by indirect haemagglutination.
    Aarli JA; Lefvert AK; Tönder O
    J Neuroimmunol; 1981 Dec; 1(4):421-7. PubMed ID: 7346525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymus, thymoma and myasthenia gravis.
    Fujii Y
    Surg Today; 2013 May; 43(5):461-6. PubMed ID: 22948665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetylcholine receptor antibody measurements in acquired myasthenia gravis. Diagnostic sensitivity and predictive value for thymoma.
    Husain AM; Massey JM; Howard JF; Sanders DB
    Ann N Y Acad Sci; 1998 May; 841():471-4. PubMed ID: 9668277
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value.
    Lindstrom JM; Seybold ME; Lennon VA; Whittingham S; Duane DD
    Neurology; 1976 Nov; 26(11):1054-9. PubMed ID: 988512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myasthenia gravis, thymectomy, and antiacetycholine receptor antibody.
    Bartoccioni E; Scuderi F; Scoppetta C; Evoli A; Tonali P; Guidi L; Bartoloni C; Terranova T
    J Neurol; 1980; 224(1):9-15. PubMed ID: 6157802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of thymoma in myasthenia gravis.
    Keesey J; Bein M; Mink J; Sample F; Sarti D; Mulder D; Herrmann C; Peter JB
    Neurology; 1980 Mar; 30(3):233-9. PubMed ID: 7189022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG subclass distribution of myasthenia gravis thymoma-associated antiskeletal muscle antibodies.
    Smith CI; Aarli JA; Hammarström L; Persson MA
    Neurology; 1984 Aug; 34(8):1094-6. PubMed ID: 6540388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myasthenia gravis and autoantibodies.
    Nishitani H
    Jpn J Med; 1988 May; 27(2):228-9. PubMed ID: 3418994
    [No Abstract]   [Full Text] [Related]  

  • 19. Heterogeneity and immunotherapy of specific T-cells in myasthenia gravis.
    Bond A; Corlett L; Nagvekar N; Jacobson L; Pantic N; Beeson D; Nicolle M; Vincent A; Newsom-Davis J; Spack E; Willcox N
    Biochem Soc Trans; 1997 May; 25(2):665-70. PubMed ID: 9191178
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunoglobulin allotypes in myasthenia gravis patients with a thymoma.
    Gilhus NE; Pandey JP; Gaarder PI; Aarli JA
    J Autoimmun; 1990 Jun; 3(3):299-305. PubMed ID: 2397020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.